Vaccinex, Inc. (VCNX) Stock Forecast

OTC Pink: VCNXAnalyst ratings, price target and estimates.

VCNX analyst forecast

as of October 20, 2026
Analyst consensus
Buy
4.00 / 5 from 2 analysts
Price target
$7.00
average of analyst targets
Upside to target
+921.9%
from the latest close
Next earnings
—
52-week range
$0.34 – $1.49

VCNX analyst ratings

2 analysts
Strong buy
150%
Buy
00%
Hold
150%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

VCNX price target

Price $0.69Target $7.00
52-week low $0.3452-week high $1.49

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

VCNX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; VCNX beat in 7 of 8.

What analysts expect from VCNX

2 analysts cover Vaccinex; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.00, 921.9% above the latest close of $0.69. Vaccinex beat the EPS estimate in 7 of the last 8 quarters.

Related: VCNX income statement, VCNX key metrics, VCNX chart. See the VCNX stock overview for the latest quote and news.

VCNX forecast FAQ

What is Vaccinex's price target?

The average analyst price target for Vaccinex is $7.00, 921.9% above the latest close of $0.69.

Is Vaccinex a buy, hold or sell?

Of 2 analysts covering Vaccinex, 1 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

Does Vaccinex usually beat earnings estimates?

Vaccinex reported EPS at or above the analyst estimate in 7 of the last 8 quarters.

Biotechnology: forecast